{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:27:05Z","timestamp":1787009225106,"version":"build-2736575974"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Coccidioidomycosis is an endemic fungal infection caused by the soil-dwelling Coccidioides. One prior study showed that persons with diabetes mellitus (DM) with elevated glucose at the time of coccidioidomycosis had poorer coccidioidal outcomes compared to persons without DM. We aimed to assess the association between hemoglobin A1C (A1C) and outcomes among persons with coccidioidomycosis and coexisting DM. We conducted a retrospective case-control study of patients with DM (cases) and without DM (controls) with coccidioidomycosis to assess the effect of glycemic control on outcomes in patients with DM. From January 1, 2017, to October 13, 2022, we identified 138 DM patients with coccidioidomycosis and compared them with 283 non-DM control patients with coccidioidomycosis. Compared with controls, cases were more likely to require hospitalization (OR 1.20, P\u00a0&amp;lt;\u00a0.001), have a lung cavity (OR 1.36, P\u00a0&amp;lt;\u00a0.001) and cavitary complications (OR 1.09, P\u00a0=\u00a0.001), require surgical management (OR 1.07, P\u00a0=\u00a0.016), and experience relapsed infection (OR 1.09, P\u00a0=\u00a0.041). Among the cases, when baseline A1C was assessed as a continuous variable, each 1-unit increase of A1C had a significant effect on coccidioidomycosis-related hospitalizations (A1C OR 1.59, P\u00a0=\u00a0.005) and the presence of cavities (OR 1.42, P\u00a0=\u00a0.01). Controlling for Charlson Comorbidity Index did not change the significance of A1C influence on outcomes of hospitalization and lung cavities. DM patients with A1C levels\u00a0\u22648.0 at presentation did not have increased adverse coccidioidomycosis outcomes. In summary, glycemic control profoundly impacts the outcomes of diabetic patients with coccidioidomycosis.<\/jats:p>","DOI":"10.1093\/mmy\/myaf004","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T23:17:03Z","timestamp":1737847023000},"source":"Crossref","is-referenced-by-count":6,"title":["The profound effect of diabetes mellitus control on outcomes of coccidioidomycosis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4349-6913","authenticated-orcid":false,"given":"Rawan","family":"El\u00a0Kurdi","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic Arizona, \u00a0 Phoenix, Arizona ,","place":["USA"]},{"name":"Department of Internal Medicine, Banner University Hospital , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6654-570X","authenticated-orcid":false,"given":"Alyssa","family":"McGary","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic Arizona , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-0989","authenticated-orcid":false,"given":"Matthew R","family":"Buras","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic Arizona , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-1986","authenticated-orcid":false,"given":"Patricia M","family":"Verona","sequence":"additional","affiliation":[{"name":"Department of Information Technology Division of Data Analysis & Integration Services, Mayo Clinic Arizona , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-9959","authenticated-orcid":false,"given":"Curtiss B","family":"Cook","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic Arizona , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-1473","authenticated-orcid":false,"given":"Janis E","family":"Blair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic Arizona, \u00a0 Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"2025030418401536400_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40121-022-00606-y","article-title":"Coccidioidomycosis: a contemporary review","volume":"11","author":"Crum","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"Suppl 1","key":"2025030418401536400_bib2","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"2025030418401536400_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2025030418401536400_bib4","article-title":"Diabetes mellitus and infections","volume-title":"Endotext","author":"Zhou","year":"2000"},{"key":"2025030418401536400_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"2025030418401536400_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van\u00a0den\u00a0Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"2025030418401536400_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control","volume":"31","author":"Van\u00a0den\u00a0Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"2025030418401536400_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/319203","article-title":"Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995\u20131996","volume":"32","author":"Rosenstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2025030418401536400_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.amjmed.2006.03.033","article-title":"Coccidioidomycosis in patients with diabetes mellitus","volume":"119","author":"Santelli","year":"2006","journal-title":"Am J Med"},{"key":"2025030418401536400_bib10","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1017\/S0950268820002836","article-title":"Sociodemographic factors associated with patients hospitalised for coccidioidomycosis in California and Arizona, State Inpatient Database 2005\u20132011","volume":"149","author":"Kupferwasser","year":"2021","journal-title":"Epidemiol Infect"},{"key":"2025030418401536400_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025030418401536400_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0021-9681(76)90073-4","article-title":"How many controls","volume":"29","author":"Gail","year":"1976","journal-title":"J Chron Dis"},{"key":"2025030418401536400_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v111.i09","article-title":"How to interpret statistical models using marginaleffects for R and Python","volume":"111","author":"Arel-Bundock","year":"2024","journal-title":"J Stat Softw"},{"key":"2025030418401536400_bib14","first-page":"378","article-title":"glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling","volume":"9","author":"Brooks","year":"2017","journal-title":"R Journal"},{"key":"2025030418401536400_bib15","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc24-S006","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025030418401536400_bib16","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc24-S013","article-title":"13. Older adults: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025030418401536400_bib17","doi-asserted-by":"crossref","first-page":"e00028","DOI":"10.1128\/IAI.00028-18","article-title":"Myeloid differentiation factor 88 and interleukin-1R1 signaling contribute to resistance to Coccidioides immitis","volume":"86","author":"Viriyakosol","year":"2018","journal-title":"Infect Immun"},{"key":"2025030418401536400_bib18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1128\/IAI.01066-15","article-title":"Card9- and MyD88-mediated gamma interferon and nitric oxide production is essential for resistance to subcutaneous Coccidioides posadasii infection","volume":"84","author":"Hung","year":"2016","journal-title":"Infect Immun"},{"key":"2025030418401536400_bib19","doi-asserted-by":"crossref","first-page":"581101","DOI":"10.3389\/fcimb.2020.581101","article-title":"Host response to Coccidioides infection: fungal immunity","volume":"10","author":"Diep","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2025030418401536400_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.vaccine.2005.07.092","article-title":"Molecular and cellular mechanisms of protective immunity to coccidioidomycosis","volume":"24","author":"Kirkland","year":"2006","journal-title":"Vaccine"},{"key":"2025030418401536400_bib21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1464-5491.2005.01626.x","article-title":"Hyperglycaemia and mortality of diabetic patients with candidaemia","volume":"22","author":"Bader","year":"2005","journal-title":"Diabet Med"},{"key":"2025030418401536400_bib22","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"2025030418401536400_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/cid\/cir939","article-title":"The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study","volume":"54","author":"Baker","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025030418401536400_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1586\/eri.12.75","article-title":"Managing tuberculosis in patients with diabetes mellitus: why we care and what we know","volume":"10","author":"Jeon","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025030418401536400_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/thoraxjnl-2012-201756","article-title":"Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes","volume":"68","author":"Jimenez-Corona","year":"2013","journal-title":"Thorax"},{"key":"2025030418401536400_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/am.20.3.328-332.1970","article-title":"Comparison of methods for coccidioidomycosis complement fixation","volume":"20","author":"Huppert","year":"1970","journal-title":"Appl Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf004\/61652276\/myaf004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf004\/61652276\/myaf004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf004\/61652276\/myaf004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:47:01Z","timestamp":1741103221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf004\/7984483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf004","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,25]]},"article-number":"myaf004"}}